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ABSTRACT: A number of serological tests were compared for the detection of antibodies to
Brucella abortus in bison (Bison bison). The performance of the fluorescence polarization assay
(FPA) in both the preliminary evaluation and a subsequent blind validation indicated that this
test was the most suitable for serological diagnosis of brucellosis in bison. The sensitivity and
specificity in the preliminary evaluation were 92.1% and 99.4%, respectively. The sensitivity and
specificity in a subsequent blind study were 96.3% and 97.6%, respectively. In a double blind
study conducted on bison vaccinated with B. abortus strain 19, the data suggests that the FPA
can differentiate bison infected with B. abortus from bison vaccinated with B. abortus strain 19.
Both the indirect immunoassay (IELISA) and the competitive immunoassay (CELISA) performed
nearly as well as the FPA. The buffered antigen plate agglutination test (BPAT) and the complement fixation test (CFT) did not perform as well as the FPA, CELISA or the IELISA in both
studies. The FPA is a homogeneous assay eliminating the washing steps and reducing incubation
to minutes rather than hours saving on time, equipment, materials, reagents and cost. These
attributes, together, with its excellent sensitivity and specificity make the FPA an attractive test
for the detection of serum antibodies to Brucella abortus in bison.
Key words: Bison, Brucella abortus, competitive enzyme immunoassay, fluorescence polarization assay, validation.

INTRODUCTION

The first published paper on the serological diagnosis of brucellosis using an agglutination test was by Wright and Smith
(1897). Since then, the diagnosis of brucellosis has been accomplished using a variety of tests that vary in their ability to
detect antibodies to Brucella abortus and
as a consequence their diagnostic sensitivity and specificity. All these tests and their
subsequent modifications were initially developed for use in cattle. Traditionally, agglutination tests which were sensitive but
not highly specific were used as screening
tests and positive results were confirmed
using more accurate but labor intensive

tests such as the complement fixation test.
Primary binding assays have greater accuracy and some can differentiate animals
vaccinated with B. abortus strain 19 from
infection induced by field strains (MacMillan et al., 1990; Nielsen et al., 1989,
1995, 1996b; Rylatt et al., 1985). These assays can be tailored for diagnosis of brucellosis in non-cattle species that may impact on the cattle industry. As early as
1917, brucellosis in bison (Bison bison)
was a concern (Mohler, 1917) and has remained so, particularly in cattle ranches or
farms adjacent to game ranches (Bulmer,
1989) or National Parks such as Yellowstone (USA) (DeYoung, 1973; Cohn,
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1991). It is important to accurately diagnose brucellosis in bison (Tessaro, 1986,
1989), since Canadian cattle are considered free of bovine brucellosis and infected bison might pose a significant threat to
agriculture and export markets.
Primary binding assays for brucellosis
were developed to improve the diagnostic
sensitivity and specificity of serological
tests for cattle and can be adapted for use
in bison. The indirect enzyme immunoassay (IELISA) is highly sensitive and can
be modified for bison using a monoclonal
antibody produced against the bovine immunoglobulin light chain that cross reacts
with the bison immunoglobulin light
chain (Henning and Nielsen, 1992). However, the IELISA cannot differentiate
vaccinal antibody or antibody from cross
reacting microorganisms from antibody
resulting from field infection. The competitive enzyme immunoassay (CELISA)
which can differentiate as described by
Nielsen et al. (1995, 1996a) is also capable of detecting antibodies to B. abortus
in other species.
The fluorescence polarization assay
(FPA) (Nielsen et al., 1996b) like the
CELISA has the capability to differentiate
field infection from vaccine and cross reactions, requires minimal manipulations,
uses less equipment and can be completed
in less than five minutes (Nielsen et al.,
1996b). Because of this and its performance characteristics, it is a near ideal test
for the detection of antibody to B. abortus
in bison.
MATERIALS AND METHODS
Serological tests

The buffered antigen plate agglutination test
(BPAT) was performed as described in the Office International des Epizooties (1996). Manual of standards for diagnostic tests and vaccines.
The complement fixation test (CFT) was
done as described by Samagh and Boulanger
(1978). The IELISA was performed as described by Nielsen et al. (1996a). The IELISA
used smooth lipopolysaccharide (sLPS) from B.
abortus as the antigen adsorbed onto a polystyrene microplate and followed stepwise by the

application of the diluted serum samples; murine monoclonal antibody anti-bovine light
chain (M4-1) conjugated with horseradish peroxidase (Henning and Nielsen, 1992) and substrate/chromogen. Divalent cation chelating
agents (EDTA/EGTA) were added to the serum diluent to minimize nonspecific interactions (Nielsen et al., 1994) and the microplate
was washed between each step with 0.01 M,
pH 7.2 phosphate buffer saline containing 0.15
M NaCl and 0.05% Tween-20 (PBS/T).
The CELISA was performed as described
by Nielsen et al. (1996a). As in the IELISA,
the CELISA used sLPS antigen adsorbed onto
a polystyrene microplate. After incubation and
washing, diluted serum samples were added
immediately followed by the addition of a murine monoclonal antibody (M84) specific for a
B. abortus O-polysaccharide epitope. The serum samples were diluted in PBS/T containing
EDTA/EGTA (Nielsen et al., 1994). The serum samples and the M84 were mixed for
three minutes and incubated for thirty minutes. After incubation and washing, commercial goat antimouse IgG horseradish peroxidase conjugated antibody (heavy and light specific) was added which was followed by the
addition of substrate/chromogen after incubation and washing.
The FPA was performed as described by
Nielsen et al. (1996b). The assay uses B. abortus O-polysaccharide conjugated with fluorescein isothiocyanate (FITC). The assay involves
the addition of a serum at 1/100 in 2 ml of 0.1
M sodium phosphate, pH 7.4, containing 0.15
M NaCl, 0.1% sodium azide and 0.05% lithium
dodecyl sulfate (PBSAL). The sample was tested in a fluorescence polarization analyzer
(FPM-1, Jolley Consulting and Research Inc.,
Round Lake, Illinois, USA) to obtain a baseline
measurement. Next a predetermined amount
of the conjugated antigen in 0.01 M sodium
phosphate, pH 7.4 containing 0.15 M NaCl and
0.1% sodium azide is added, mixed and incubated for approximately two minutes to allow
for interaction between the antigen and antibody that may be present. After incubation, the
sample was measured in the fluorescence polarization analyzer. In the presence of antibody,
a high millipolarization (mP) result was obtained, while in the absence of an antibrucella
antibody, a low mP result was apparent.
Serum samples

Bison sera for the preliminary evaluation
were obtained from areas where no clinical or
epidemiological evidence of brucellosis was apparent for the specificity studies. Of these, approximately, 1,000 samples initially submitted
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for diagnostic screening of brucellosis were
tested by the BPAT, CELISA and IELISA.
These samples were later supplemented with
another 1,807 diagnostic samples from the
same source for the comparison of the CFT
and FPA (2,807 samples). Vaccination of bison
with B. abortus strain 19 or RB51 is not currently practiced in Canada.
Positive samples for the preliminary study (n
⫽ 38) were collected from bison from which
field strains of Brucella abortus had been isolated from various tissues after slaughter. These
samples were collected from bison in Wood
Buffalo National Park (n ⫽ 5), the United
States (n ⫽ 15) and Ontario (n ⫽ 18).
In a subsequent blind study bison sera from
223 animals of known culture status were evaluated using the cutoffs previously determined.
Nine sera were not tested due to insufficient
volume and of the 214 remaining sera, 54 were
from animals in which B. abortus had been isolated.
Bison sera from three animals inoculated
with B. abortus strain 19 were evaluated with
the CELISA and FPA tests in a double blind
study. They were subsequently challenged with
B. abortus strain 2308.

TABLE 1. Comparison of sensitivity and specificity
estimates for serological tests for brucellosis in bison.

Data handling and analysis

results treated as negative). The specificity
of the BPAT (91.7%) did not exceed the
other assays except for the CFT (65.1%
with the AC results as positive). The sensitivity/specificity of the complement fixation test did not exceed the other tests depending on how the AC results were treated.
The specificity of the FPA was 99.4%,
exceeding both the CELISA (98.4%) and
IELISA (96.2%). Although, the sensitivity
of the IELISA was 100%, it is unable to
distinguish animals that have been vaccinated with strain 19 or infected with crossreacting microorganisms from animals infected with B. abortus, probably accounting for its lower specificity (96.2%).
Both the CELISA and FPA are multi
species assays with the capability to distinguish Brucella infected animals from B.
abortus strain 19 vaccinated animals and
from animals infected with cross-reacting
microorganisms. Although these two assays both had sensitivity values of 92.1%,
the specificity of the FPA was higher at
99.6% thus giving it a slight advantage over

A combination of statistical analysis and
graphical presentation were used to determine
the initial cutoff and the diagnostic sensitivity
and specificity of the various assays for bison.
The data was first analyzed using receiver operating characteristics (ROC) analysis (Schoojans et al., 1995). This analysis determined the
cutoff to achieve the optimum sensitivity and
specificity, as well as determining sensitivity
and specificity values for other cutoffs. For visual confirmation, frequency distribution of the
data was used.
The ELISA software used for the CELISA
and IELISA was developed at the Animal Diseases Research Institute (ADRI) and is available upon request from (W. Kelly, Canadian
Food Inspection Agency, Animal Diseases Research Institute, Nepean, Ontario, Canada).
RESULTS

The preliminary data presented in Table
1 compares the actual sensitivity based on
culture results and the specificity based on
no previous clinical or epidemiological evidence of brucellosis in the bison. The sensitivity of the BPAT (92.1%) did not exceed the other assays except for the CFT
(89.5% with the anti-complementary (AC)

Test

BPATa
CFTb
CFTc
CELISAd
IELISAe
FPAf

% sensitivity
(n)

92.1
89.5
97.4
92.1
100
92.1

(38)
(38)
(38)
(38)
(38)
(38)

% specificity
(n)

Performance
indexg

91.7
95.5
65.1
98.4
96.2
99.4

183.8
185.0
162.5
190.5
196.2
191.5

(1,000)
(2,807)
(2,807)
(1,000)
(1,044)
(2,807)

a

Buffered antigen plate agglutination test, either positive or
negative.
Complement fixation test cutoff ⱖ 1/5. AC refers to anticomplementary samples. AC reactions treated as negative.
c Anticomplementary reactions treated as positive.
d Competitive enzyme immunoassay using a cutoff of 29 percent inhibition.
e Indirect enzyme immunoassay using a cutoff of 39 percent
positivity.
f Fluorescence polarization assay using a cutoff of 85 millipolarization units.
g Performance index is percent sensitivity plus percent specificity.
b
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FIGURE 1a–d. The receiver operating characteristic curve is presented for each assay. The cutoff
value for each assay is in the upper right-hand corner of each curve. Figure 1a is the complement fixation test with a optimal cutoff value greater than
or equal to a 1/5 dilution. Figure 1b is the competitive enzyme immunoassay with a optimal cutoff value of 29% inhibition. Figure 1c is the indirect enzyme immunoassay with an optimal cutoff value of
39% positivity. Figure 1d is the fluorescence polarization assay with an optimal cutoff value of 85 millipolarization units.

the CELISA resulting in 10 fewer animals
per 1,000 incorrectly diagnosed.
The cutoffs for each assay except for the
BPAT were initially determined using
ROC analysis and are presented in Figure
1a to 1d. This analysis determines sensitivity and specificity values at various cutoff
values and determines the optimal sensitivity and specificity for each assay and
provides the ability to compare assays using different measurement units. For instance, the CFT uses dilutions, the CELISA percent inhibition, the IELISA percent positivity and the FPA millipolarization units. The ROC analysis of the CFT
data as presented in Figure 1a included
anti-complementary results which were
treated as negative results. This resulted in
an optimal sensitivity of 89.5% and a specificity of 95.5% at a cutoff greater than or
equal to 1/5 dilution. One of the difficul-

ties with the CFT is the interpretation of
anticomplementary data. As indicated in
Table 1 this can affect the determination
of the sensitivity and specificity of the assay. The other assays do not have this
problem.
In Figure 1b, the cutoff of the CELISA
was 29% inhibition giving an optimal sensitivity of 92.1% and a specificity of 98.4%,
while in Figure 1c the cutoff of the IELISA was 39% positivity for an optimal sensitivity of 100% and specificity of 96.2%.
Figure 1d, the ROC curve for the FPA,
determined a cutoff of 85 mP for an optimal sensitivity of 92.1% and specificity of
99.4%.
Receiver operating characteristics analysis can also determine the area under the
curve (AUC). As an example, an AUC of
0.95 indicates that a randomly selected individual animal from a positive population
will have a test value greater than a randomly selected individual animal from a
negative population 95% of the time. The
lowest AUC was for the CFT (0.923) while
the highest AUC was for the IELISA
(0.998). However, since the IELISA is unable to distinguish cattle infected with B.
abortus from those vaccinated with strain
19 or infected with cross reacting microorganisms, the FPA with an AUC of 0.960
is a more accurate test followed by the
CELISA with an AUC of 0.945.
The frequency distribution of the data
for each assay is presented in Figure 2a to
2d. From these figures it would be difficult
to determine the cutoff for each assay as
some overlap between the negative and
positive populations are apparent. This is
quite obvious in Figure 2b for the CELISA and Figure 2d for the FPA data. Therefore, ROC analysis was used to determine
the cutoff values for optimal sensitivity and
specificity. These values were then visually
confirmed using frequency distributions.
The advantage of using frequency distributions in combination with ROC analysis
is the ability to visualize the number of
false positives and false negatives after the
cutoff has been determined. For instance,
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BPAT had a sensitivity of 81.5%. The
BPAT, IELISA and the FPA had the highest specificity of 97.6%. The CFT and the
CELISA had a specificity of 91.7% and
94.1%, respectively.
Data presented in Table 3 compare the
FPA and the CELISA using sera from bison inoculated with B. abortus strain 19
and subsequently challenged with B. abortus strain 2308. With one exception (4 wk
PI) both the FPA and the CELISA were
able to differentiate post-inoculation sera
from post-challenged sera. Brucella abortus was isolated in two of the three bison
after challenge.
The performance index presented in Tables 1 and 3 is the sum of the sensitivity
value plus the specificity value. Both the
IELISA and the FPA have the highest index in both studies. The BPAT has the
lowest index in both studies.
DISCUSSION

FIGURE 2a–d. The frequency distribution for
each assay is presented. The overlap of data varies for
each distribution. Open bars are negative and closed
bars are positive. The data above each bar, indicate
the number of observations for that class interval.
Figure 2a is the complement fixation test. Figure 2b
is the competitive enzyme immunoassay. Figure 2c is
the indirect enzyme immunoassay. Figure 2d is the
fluorescence polarization assay.

a cutoff of 85 mP for the FPA assay in
Figure 2d indicates that at least three samples were false positive results. Similarly, a
cutoff of 39% for the IELISA in Figure 2c
indicated that it had more false positive
results than the FPA. This was true for the
other assays as well.
In a blind study (Table 2) conducted on
214 samples of which 54 samples were
from animals from which B. abortus had
been isolated the CFT (ACs included),
CELISA, FPA and IELISA had an actual
sensitivity of 96.3%, respectively. The

The data presented in Tables 1, 2, and
3 indicated that the most suitable test
overall for diagnosis of brucellosis in bison
was the FPA followed by the IELISA,
CELISA, CFT and BPAT as indicated by
the sensitivity values, specificity values,
AUC and the performance index. The
BPAT and CFT did not perform as well as
the primary binding assays, due in part to
their reliance on secondary properties of
antibodies such as the ability to agglutinate
or to fix complement.
These assays were less specific than the
primary binding assays and were developed for the detection of serum antibody
to Brucella abortus in cattle. They were
never subjected to the same scrutiny for
validation as present day primary binding
assays. As well, the data reported in the
literature (Thorne et al., 1978; Davis et al.,
1990; Nicoletti, 1992) suggests that no single test could be relied upon to definitively
diagnose brucellosis in bison.
The IELISA used a murine monoclonal
produced against bovine immunoglobulin
light chain which cross-reacts with bison
immunoglobulin light chain (Henning and
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TABLE 2. Comparison of sensitivity and specificity estimates for serological tests for the detection of bison
serum antibody to Brucella abortus in a blind study.

Test

Sensitivity (%)
(n ⫽ 54)

Specificity (%)
(n ⫽ 160)

Performance
indexg

Buffered Antigen Plate Agglutination Testa
Complement Fixation Testb
Complement Fixation Testc
Competitive enzyme immunoassayd
Indirect enzyme immunoassaye
Fluorescence polarization assayf

81.1
94.3
96.3
96.3
96.3
96.3

97.6
91.7
91.7
94.1
97.6
97.6

178.7
186.0
188.0
190.4
193.9
193.9

a

Buffered Antigen Plate Agglutination Test, either positive or negative.
Complement Fixation Test cutoff ⱖ 1/5. AC refers to anticomplementary samples. AC reaction treated as negative.
Anticomplementary reaction treated as positive.
d Competitive enzyme immunoassay using a cutoff of 29 percent inhibition.
e Indirect enzyme immunoassay using a cutoff of 39 percent positivity.
f Fluorescence polarization assay using a cutoff of 85 millipolarization units.
g Performance index is percent sensitivity plus percent specificity.
b
c

Nielsen, 1992) resulting in a sensitivity value of 100%. The FPA and the CELISA
can distinguish over 95% of the cattle vaccinated with strain 19 (Nielsen, 1995,
1996b) or exposed to cross-reacting microorganisms from cattle infected with B.
abortus. The BPAT, CFT and the IELISA
cannot distinguish cattle vaccinated with
B. abortus strain 19 or exposed to crossreacting microorganisms from cattle inTABLE 3. Comparison of the fluorescence polarization assay and competitive enzyme immunoassay with
bison inoculated with B. abortus strain 19 and challenged with B. abortus strain 2308 in a double blind
study.

Animal

Bison
Bison
Bison
Bison
Bison
Bison
Bison
Bison
Bison

7
7
7
8
8
8
9
9
9

Time

52 wk PIa
4 wk PCb
Necropsy (12 wk PC)
52 wk PI
4 wk PC
Necropsy (12 wk PC)
4 wk PI
52 wk PC
Necropsy (12 wk PC)

Culture

⫹
⫹
⫹

FPAc

CELISAd

66.5
110.4
99.4
73.6
118.2
180.3
88.5
66.6
90.2

21
75
71
28
62
99
32
7
48

PI ⫽ weeks after inoculation with 2.3 ⫻ 1010 CFU of B.
abortus strain 19.
b PC ⫽ weeks after intra conjunctival challenge with 1 ⫻ 107
CFU of B. abortus strain 2308 at 180 days gestation.
c Fluorescence polarization assay using a cutoff of 85 millipolarization units.
d Competitive enzyme immunoassay using a cutoff of 29 percent inhibition
a

fected with B. abortus. Strain 19 vaccination of bison has been attempted in the
past in both Wood Buffalo National Park
(Choquette, 1961) and in the United
States in private herds (Flagg, 1983; Davis
et al., 1991) and strain 19 vaccinated bison
are regularly imported into Canada from
the United States. The data presented in
Table 3 suggests that both the FPA and
CELISA can differentiate bison infected
with B. abortus from bison vaccinated with
B. abortus strain 19.
For acceptance of a new test for the
presumptive diagnosis of brucellosis, it
would be required to perform as well as
or better than the in-use tests or possess
an advantageous attribute. The data in Table 2 validates the preliminary data presented in Table 1 suggesting that the FPA
is the most suitable test for the diagnosis
of brucellosis in bison reducing the need
to use a series of unvalidated conventional
serological tests.
The BPAT and the FPA are comparable
in cost and less expensive than the CELISA or the IELISA. The most expensive
test to perform is the CFT. The sensitivity
and specificity of the CFT are not comparable to those of the FPA or CELISA.
The data demonstrates that brucellosis
tests such as the BPAT and CFT which
were developed for cattle may not be the
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most suitable tests for bison or other nontraditional livestock. The bison industry in
North America continues to expand
(80,000 to 100,000 bison; Davis et al.,
1990), placing bison in close contact with
traditional livestock species. Some herds
are located close to known sources of infection such as Wood Buffalo National
Park in Canada and Yellowstone National
Park (USA). When testing bison, it is important that the most accurate test be used
to minimize the risk of missing infected
animals.
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